Modulation of Reactive Oxygen Species to Overcome 5-Fluorouracil Resistance

5-Fluorouracil (5-FU) remains to be an important chemotherapeutic drug for treating several cancers when targeted therapy is unavailable. Chemoresistance limits the clinical utility of 5-FU, and new strategies are required to overcome the resistance. Reactive oxygen species (ROS) and antioxidants ar...

Full description

Saved in:
Bibliographic Details
Published in:Biomolecules & therapeutics 2022-11, Vol.30 (6), p.479-489
Main Authors: Chun, Kyung-Soo, Joo, Sang Hoon
Format: Article
Language:English
Subjects:
Review
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c405t-944bbd8e7ce427ed5f49676d61d63668722e33ed18254b74dc43114cf24f0e823
cites cdi_FETCH-LOGICAL-c405t-944bbd8e7ce427ed5f49676d61d63668722e33ed18254b74dc43114cf24f0e823
container_end_page 489
container_issue 6
container_start_page 479
container_title Biomolecules & therapeutics
container_volume 30
creator Chun, Kyung-Soo
Joo, Sang Hoon
description 5-Fluorouracil (5-FU) remains to be an important chemotherapeutic drug for treating several cancers when targeted therapy is unavailable. Chemoresistance limits the clinical utility of 5-FU, and new strategies are required to overcome the resistance. Reactive oxygen species (ROS) and antioxidants are balanced differently in both normal and cancer cells. Modulating ROS can be one method of overcoming 5-FU resistance. This review summarizes selected compounds and endogenous cellular targets modulating ROS generation to overcome 5-FU resistance.
doi_str_mv 10.4062/biomolther.2022.017
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9622305</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2652866021</sourcerecordid><originalsourceid>FETCH-LOGICAL-c405t-944bbd8e7ce427ed5f49676d61d63668722e33ed18254b74dc43114cf24f0e823</originalsourceid><addsrcrecordid>eNpVkUtLw0AQxxdRbK1-AkFy9JK6700ughSrolLwcV42m4ldSbJ1Nyn67Y1Uq57mMP_HMD-EjgmecizpWeF84-tuCWFKMaVTTNQOGlOMRcp5xnbRmORKpjnh2QgdxPiKsVREyH00YoJzLIgao9t7X_a16ZxvE18lD2Bs59aQLN4_XqBNHldgHcSk88liDcH6BhKRzuveB98HY109WKKLnWktHKK9ytQRjr7nBD3PL59m1-nd4upmdnGX2qG0S3POi6LMQFngVEEpKp5LJUtJSsmkzBSlwBiUJKOCF4qXljNCuK0orzBklE3Q-SZ31RcNlBbaLphar4JrTPjQ3jj9f9O6pX7xa51LShkWQ8Dpd0Dwbz3ETjcuWqhr04Lvo6ZS0ExKTMkgZRupDT7GANW2hmD9hUH_YtBfGPSAYXCd_L1w6_n5O_sEzXSHgg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2652866021</pqid></control><display><type>article</type><title>Modulation of Reactive Oxygen Species to Overcome 5-Fluorouracil Resistance</title><source>Open Access: PubMed Central</source><creator>Chun, Kyung-Soo ; Joo, Sang Hoon</creator><creatorcontrib>Chun, Kyung-Soo ; Joo, Sang Hoon</creatorcontrib><description>5-Fluorouracil (5-FU) remains to be an important chemotherapeutic drug for treating several cancers when targeted therapy is unavailable. Chemoresistance limits the clinical utility of 5-FU, and new strategies are required to overcome the resistance. Reactive oxygen species (ROS) and antioxidants are balanced differently in both normal and cancer cells. Modulating ROS can be one method of overcoming 5-FU resistance. This review summarizes selected compounds and endogenous cellular targets modulating ROS generation to overcome 5-FU resistance.</description><identifier>ISSN: 1976-9148</identifier><identifier>EISSN: 2005-4483</identifier><identifier>DOI: 10.4062/biomolther.2022.017</identifier><identifier>PMID: 35440517</identifier><language>eng</language><publisher>Korea (South): The Korean Society of Applied Pharmacology</publisher><subject>Review</subject><ispartof>Biomolecules &amp; therapeutics, 2022-11, Vol.30 (6), p.479-489</ispartof><rights>Copyright © 2022, The Korean Society of Applied Pharmacology 2022</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c405t-944bbd8e7ce427ed5f49676d61d63668722e33ed18254b74dc43114cf24f0e823</citedby><cites>FETCH-LOGICAL-c405t-944bbd8e7ce427ed5f49676d61d63668722e33ed18254b74dc43114cf24f0e823</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622305/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9622305/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35440517$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chun, Kyung-Soo</creatorcontrib><creatorcontrib>Joo, Sang Hoon</creatorcontrib><title>Modulation of Reactive Oxygen Species to Overcome 5-Fluorouracil Resistance</title><title>Biomolecules &amp; therapeutics</title><addtitle>Biomol Ther (Seoul)</addtitle><description>5-Fluorouracil (5-FU) remains to be an important chemotherapeutic drug for treating several cancers when targeted therapy is unavailable. Chemoresistance limits the clinical utility of 5-FU, and new strategies are required to overcome the resistance. Reactive oxygen species (ROS) and antioxidants are balanced differently in both normal and cancer cells. Modulating ROS can be one method of overcoming 5-FU resistance. This review summarizes selected compounds and endogenous cellular targets modulating ROS generation to overcome 5-FU resistance.</description><subject>Review</subject><issn>1976-9148</issn><issn>2005-4483</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNpVkUtLw0AQxxdRbK1-AkFy9JK6700ughSrolLwcV42m4ldSbJ1Nyn67Y1Uq57mMP_HMD-EjgmecizpWeF84-tuCWFKMaVTTNQOGlOMRcp5xnbRmORKpjnh2QgdxPiKsVREyH00YoJzLIgao9t7X_a16ZxvE18lD2Bs59aQLN4_XqBNHldgHcSk88liDcH6BhKRzuveB98HY109WKKLnWktHKK9ytQRjr7nBD3PL59m1-nd4upmdnGX2qG0S3POi6LMQFngVEEpKp5LJUtJSsmkzBSlwBiUJKOCF4qXljNCuK0orzBklE3Q-SZ31RcNlBbaLphar4JrTPjQ3jj9f9O6pX7xa51LShkWQ8Dpd0Dwbz3ETjcuWqhr04Lvo6ZS0ExKTMkgZRupDT7GANW2hmD9hUH_YtBfGPSAYXCd_L1w6_n5O_sEzXSHgg</recordid><startdate>20221101</startdate><enddate>20221101</enddate><creator>Chun, Kyung-Soo</creator><creator>Joo, Sang Hoon</creator><general>The Korean Society of Applied Pharmacology</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20221101</creationdate><title>Modulation of Reactive Oxygen Species to Overcome 5-Fluorouracil Resistance</title><author>Chun, Kyung-Soo ; Joo, Sang Hoon</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c405t-944bbd8e7ce427ed5f49676d61d63668722e33ed18254b74dc43114cf24f0e823</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Review</topic><toplevel>online_resources</toplevel><creatorcontrib>Chun, Kyung-Soo</creatorcontrib><creatorcontrib>Joo, Sang Hoon</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Biomolecules &amp; therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chun, Kyung-Soo</au><au>Joo, Sang Hoon</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Modulation of Reactive Oxygen Species to Overcome 5-Fluorouracil Resistance</atitle><jtitle>Biomolecules &amp; therapeutics</jtitle><addtitle>Biomol Ther (Seoul)</addtitle><date>2022-11-01</date><risdate>2022</risdate><volume>30</volume><issue>6</issue><spage>479</spage><epage>489</epage><pages>479-489</pages><issn>1976-9148</issn><eissn>2005-4483</eissn><abstract>5-Fluorouracil (5-FU) remains to be an important chemotherapeutic drug for treating several cancers when targeted therapy is unavailable. Chemoresistance limits the clinical utility of 5-FU, and new strategies are required to overcome the resistance. Reactive oxygen species (ROS) and antioxidants are balanced differently in both normal and cancer cells. Modulating ROS can be one method of overcoming 5-FU resistance. This review summarizes selected compounds and endogenous cellular targets modulating ROS generation to overcome 5-FU resistance.</abstract><cop>Korea (South)</cop><pub>The Korean Society of Applied Pharmacology</pub><pmid>35440517</pmid><doi>10.4062/biomolther.2022.017</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1976-9148
ispartof Biomolecules & therapeutics, 2022-11, Vol.30 (6), p.479-489
issn 1976-9148
2005-4483
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9622305
source Open Access: PubMed Central
subjects Review
title Modulation of Reactive Oxygen Species to Overcome 5-Fluorouracil Resistance
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T03%3A17%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Modulation%20of%20Reactive%20Oxygen%20Species%20to%20Overcome%205-Fluorouracil%20Resistance&rft.jtitle=Biomolecules%20&%20therapeutics&rft.au=Chun,%20Kyung-Soo&rft.date=2022-11-01&rft.volume=30&rft.issue=6&rft.spage=479&rft.epage=489&rft.pages=479-489&rft.issn=1976-9148&rft.eissn=2005-4483&rft_id=info:doi/10.4062/biomolther.2022.017&rft_dat=%3Cproquest_pubme%3E2652866021%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c405t-944bbd8e7ce427ed5f49676d61d63668722e33ed18254b74dc43114cf24f0e823%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2652866021&rft_id=info:pmid/35440517&rfr_iscdi=true